Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +8.77% | +9.73% | +22.77% |
05-15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
05-14 | Passage Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.77% | 76.43M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.19% | 22.48B | |
-9.91% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating